Core Viewpoint - The Beauty Health Company will report its second quarter 2025 financial results on August 7, 2025, after market close, followed by an investor conference call [1]. Group 1: Financial Reporting - The financial results will be announced in a press release, and an investor conference call is scheduled for 4:30 p.m. Eastern Time on the same day [1]. - A live webcast of the call will be available on the company's investor relations website, with a recording accessible approximately three hours after the call concludes [2]. Group 2: Disclosure Practices - The company utilizes various means to disclose material information, including SEC filings, press releases, public conference calls, and its investor relations website, in compliance with Regulation FD [3]. Group 3: Company Overview - The Beauty Health Company (NASDAQ: SKIN) combines medtech and beauty, providing millions of skin health experiences annually, focusing on consumer relationships with skin and self-confidence [4]. - The company's flagship brands include Hydrafacial™ for hydradermabrasion, SkinStylus™ for microneedling, and Keravive™ for scalp health, aiming to personalize skin health for diverse demographics [4]. - The company emphasizes a commitment to mindful business practices that positively impact communities and the environment [4].

Core Viewpoint - The Beauty Health Company has announced a refinancing initiative aimed at strengthening its financial position and extending the maturity of a portion of its existing debt, which will facilitate long-term growth investments [2]. Group 1: Refinancing Details - The company has entered into exchange agreements to swap approximately $413.2 million of existing 1.25% convertible senior notes due 2026 for $250.0 million of new 7.95% convertible senior secured notes due 2028, along with approximately $143.4 million in cash [2]. - The new notes will be senior, secured obligations guaranteed by certain subsidiaries and will bear an interest rate of 7.95% per annum [2]. - The initial conversion rate for the new notes is set at 349.6503 shares per $1,000 principal amount, translating to a conversion price of approximately $2.86 per share [2]. Group 2: Strategic Focus - The CEO emphasized that the refinancing is a critical step in enhancing the company's financial flexibility, allowing for investments in innovation and brand initiatives [2]. - The company aims to improve commercial execution, accelerate product development, and deepen engagement with providers [2]. Group 3: Transaction Advisors - Goldman Sachs is serving as the exclusive financial advisor for the transaction, while Latham & Watkins LLP is acting as transaction counsel [3].

Core Viewpoint - The Beauty Health Company will report its first quarter 2025 financial results on May 8, 2025, and will host an investor conference call shortly after the announcement [1]. Group 1: Financial Reporting - The financial results will be released after market close on May 8, 2025 [1]. - An investor conference call is scheduled for 4:30 p.m. Eastern Time on the same day [1]. Group 2: Investor Relations - A live webcast of the investor call will be available on the company's investor relations website [2]. - A recording of the call will be accessible approximately three hours after its conclusion [2]. Group 3: Company Overview - The Beauty Health Company (NASDAQ: SKIN) focuses on skin health experiences through its flagship brand Hydrafacial™ and other brands like SkinStylus™ and Keravive™ [4]. - The company aims to personalize skin health for diverse demographics and is committed to positive community and environmental impact [4].